Speaker Details

Kenneth B. Gordon, MD, FAAD

Kenneth B. Gordon, MD, FAAD

SESSIONS

S023 Psoriasis: Modern Therapeutic Approaches
Mar 8, 2025 9:00 AM - 12:00 PM Valencia Ballroom D
S028 Late-breaking Research: Session 1
Mar 8, 2025 9:00 AM - 12:00 PM Chapin Theater - Level III
S040 Late-Breaking Research: Session 2
Mar 8, 2025 1:00 PM - 4:00 PM Chapin Theater - Level III
S035 Psoriasis
Mar 8, 2025 1:00 PM - 4:00 PM Valencia Ballroom D

DISCLOSURES

AbbVie – Consultant(Honoraria), Investigator(Grants/Research Funding); Almirall – Consultant(Honoraria); Amgen – Consultant(Honoraria); Arcutis, Inc. – Consultant(Honoraria); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant(Honoraria); Dermavant Sciences – Consultant(Honoraria); Eli Lilly and Company – Investigator(Grants/Research Funding); Incyte Corporation – Consultant(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Leo Pharma Inc – Consultant(Honoraria); Lilly ICOS LLC – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria); Othro Dermatologics – Consultant(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Protagonist Therapeutics – Consultant (1099 relationship)(Honoraria); Sanofi Genzyme – Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); UCB – Consultant(Honoraria);